How do you treat intrinsic sphincter deficiency and sensory neurogenic bladder dysfunction in patients after spinal surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Intrinsic Sphincter Deficiency and Sensory Neurogenic Bladder Dysfunction After Spinal Surgery

For intrinsic sphincter deficiency after spinal surgery, offer slings as first-line surgical treatment in appropriately selected patients with acceptable bladder storage parameters, or consider artificial urinary sphincter in select cases, while for sensory neurogenic bladder dysfunction, initiate clean intermittent catheterization combined with anticholinergic medications to achieve low-pressure storage and complete emptying. 1

Initial Assessment and Risk Stratification

Before initiating any treatment, you must perform urodynamic studies to assess bladder storage parameters and ensure that outlet procedures will not create dangerously elevated storage pressures that threaten upper urinary tract function. 1 This is absolutely critical because worsening bladder compliance from an outlet procedure can lead to renal damage in patients with relevant neurogenic lower urinary tract dysfunction. 1

Key assessment parameters include:

  • Voluntary anal contraction (VAC) presence—95.7% of patients without VAC have persistent impaired bladder function at follow-up 2
  • Perineal sensation—absence of pinprick sensation in the perineal area predicts poor bladder recovery 1
  • Urethral and rectal sphincter function—reappearance of voluntary external anal/urethral sphincter contraction significantly correlates with bladder recovery (P < 0.01) 1
  • Post-void residual volumes to identify overflow incontinence 3

Treatment Algorithm for Intrinsic Sphincter Deficiency

First-Line Surgical Options

Slings should be offered to patients with stress urinary incontinence who can spontaneously void. 1 The AUA/SUFU guidelines provide a moderate recommendation (Grade C evidence) for this approach. 1 If there is concern for future need for clean intermittent catheterization, use autologous fascia or other biologic grafts rather than synthetic materials. 1

Second-Line Surgical Options

Artificial urinary sphincter (AUS) may be offered to select patients with acceptable bladder storage parameters. 1 However, you must counsel patients about:

  • Risk of voiding dysfunction requiring clean intermittent catheterization post-implantation 1
  • Need for adequate upper extremity function to manipulate the AUS device 1
  • Failure rates of approximately 24% at 5 years and 50% at 10 years 3

Minimally Invasive Options

Urethral bulking agents may be considered but counsel patients that efficacy is modest and cure is rare. 1 This is a conditional recommendation with Grade C evidence, and there is a paucity of literature evaluating this treatment specifically in neurogenic bladder populations. 1

Last Resort Option

Bladder neck closure with concomitant bladder drainage may be offered to patients with refractory stress urinary incontinence after thorough discussion of risks. 1 This irreversible procedure is reserved for patients who have failed all other forms of urethral reconstruction or have severe urethral pathologies such as strictures or urethrocutaneous fistula. 1 Continence rates range from 75-100%, but fistulization with recurrent incontinence occurs in up to 25% of cases. 1

Treatment Algorithm for Sensory Neurogenic Bladder Dysfunction

First-Line Conservative Management

Initiate clean intermittent catheterization (CIC) as the primary bladder emptying method rather than indwelling catheters. 1 This is a strong recommendation (Grade C evidence) because CIC has significantly lower rates of urinary tract infections, urethral trauma, and bladder stones compared to indwelling catheters. 1 The best quality of life is associated with ability to self-catheterize. 1

Combine CIC with anticholinergic medications or beta-3 adrenergic receptor agonists to improve bladder storage parameters. 1 The primary goal is to achieve adequate bladder drainage, low-pressure urine storage, and low-pressure voiding to prevent urinary tract infections, bladder wall damage, vesicoureteral reflux, and stone disease. 4

Second-Line Medical Management

For patients refractory to oral medications, offer onabotulinumtoxinA (200-300 units) intradetrusor injections. 1 This reduces incontinence episodes, increases maximum cystometric capacity, and decreases maximum detrusor pressure. 1 However, you must discuss the specific risk of urinary retention (20.49% vs 3.67% for placebo) and potential need for intermittent catheterization prior to treatment. 1

There is no efficacy difference between 200 U and 300 U doses, but there is an increasing dose-dependent relationship regarding retention risk and need for CIC. 1

Surgical Options for Refractory Cases

For male patients with detrusor sphincter dyssynergia who are unwilling or unable to perform CIC, offer sphincterotomy. 1 This irreversible procedure allows reflex voiding with condom catheter drainage and can increase bladder emptying effectiveness, decrease UTIs, and preserve upper urinary tract function. 1 However, counsel patients about high risk of failure or need for additional treatment. 1

For patients refractory to all therapies with elevated storage pressures, strongly consider bladder augmentation or urinary diversion. 1 These are last-resort options when stepwise therapy fails to achieve safe storage pressures. 1

Critical Monitoring Requirements

Perform urodynamic studies at appropriate intervals to assess treatment effectiveness, particularly after sphincterotomy or any outlet procedure. 1 Multichannel urodynamics documents reduction in intravesical storage pressures and confirms efficacy. 1

Assess patients annually with focused history, physical exam, basic metabolic panel, and urinary tract imaging if they have undergone lower urinary tract reconstruction incorporating bowel segments. 1 These patients are at risk for metabolic disturbances, recurrent UTIs, and malignancy. 1

Common Pitfalls to Avoid

Do not perform outlet procedures (slings, AUS, bladder neck closure) without first confirming acceptable bladder storage parameters on urodynamics. 1 Worsening bladder compliance from increased outlet resistance can create dangerously elevated storage pressures that damage the upper urinary tracts. 1

Do not recommend indwelling catheters when CIC is feasible. 1 Indwelling catheters have significantly higher complication rates including UTIs, bladder stones, and worse quality of life. 1 For patients requiring chronic indwelling catheterization, suprapubic catheterization is strongly recommended over urethral catheters. 1

Do not delay urodynamic evaluation in patients with spinal cord injury. 5 In a long-term study, treatment strategy had to be modified in almost all patients (97%), with 18.8% requiring surgery to protect upper urinary tracts. 5 Regular urodynamic follow-up is warranted for maintenance of continence and renal protection. 5

Do not assume bladder function is static after spinal surgery. 2 Bladder dysfunction is dynamic following traumatic spinal cord injury, and 94.7% of patients diagnosed with bladder dysfunction during acute care reported impaired function at 3-month follow-up. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation and Management of Urinary Incontinence in Men

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Long-term urologic management of the patient with spinal cord injury.

The Urologic clinics of North America, 1993

Related Questions

What is the best treatment for neurogenic bladder and sexual dysfunction in a patient with a history of spinal cord injury?
How to manage neurogenic bladder in spinal cord injury patients?
What is the chance of motor recovery in a 24-year-old patient with a D5 (fifth thoracic vertebra) burst fracture, anterolisthesis of D4 (fourth thoracic vertebra) over D5, dorsal spinal cord injury with paraplegia (American Spinal Injury Association (ASIA) A Injury), and bladder involvement, after undergoing D2-D8 (second to eighth thoracic vertebrae) posterior instrumented stabilization?
Do bladder spasms cause difficulty in managing spinal cord injury (SCI) patients?
Can a patient with a history of a fall, who ambulates without difficulty, plays badminton, and walks up and down stairs, still have a spinal cord injury or other neurological condition, given symptoms of incomplete bladder emptying, numbness, and pain?
What is the treatment approach for a patient suspected of having giant cell arteritis, a condition characterized by inflammation of the blood vessels?
What is the recommended treatment with steroid cream for a patient with venous reflux dermatitis, considering potential comorbidities such as diabetes (diabetes mellitus) and hypertension?
What is the recommended approach to pain management for patients undergoing opioid-free anesthesia?
Is it safe to add citalopram to the medication regimen of a geriatric patient with a history of lacunar ischemic infarction and neurocognitive trouble, who is currently taking Effexor (venlafaxine), Rexulti, and Ativan (lorazepam)?
What are the implications and management of a positive Antinuclear Antibody (ANA) screen with a titer of 1:80 in an asymptomatic adult female with no prior history of autoimmune diseases?
What is the best treatment approach for a 40-year-old patient with severe Major Depressive Disorder (MDD), characterized by anhedonia, decreased appetite, decreased libido, tearfulness, and passive suicidal ideation, with a Patient Health Questionnaire-9 (PHQ-9) score of 23, and a history of partial response to sertraline (Zoloft) (selective serotonin reuptake inhibitor (SSRI)) but with side effects of sedation and fatigue?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.